These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 22551315

  • 1. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
    Wang FF, Zhu LA, Zou YQ, Zheng H, Wilson A, Yang CD, Shen N, Wallace DJ, Weisman MH, Chen SL, Lu LJ.
    Arthritis Res Ther; 2012 May 02; 14(3):R103. PubMed ID: 22551315
    [Abstract] [Full Text] [Related]

  • 2. [The relationship between mRNA level of glucocorticoid receptor α, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
    Guan Y, Zhang Y, Fang M, Guan J, Sun X, Zhang J.
    Zhonghua Nei Ke Za Zhi; 2015 Nov 02; 54(11):922-6. PubMed ID: 26759210
    [Abstract] [Full Text] [Related]

  • 3. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L.
    Lupus; 2017 Jan 02; 26(1):62-72. PubMed ID: 27230555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus].
    Chen WY, Li GR, Fang F, Yang X, He XS, Zhou FY, Yu XQ.
    Zhonghua Nei Ke Za Zhi; 2004 Aug 02; 43(8):572-5. PubMed ID: 15355659
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
    Bilsborrow JB, Doherty E, Tilstam PV, Bucala R.
    Expert Opin Ther Targets; 2019 Sep 02; 23(9):733-744. PubMed ID: 31414920
    [Abstract] [Full Text] [Related]

  • 7. Steroid Resistance Associated with High MIF and P-gp Serum Levels in SLE Patients.
    Beltrán-Ramírez A, Muñoz-Valle JF, Gamez-Nava JI, Saldaña-Cruz AM, Gonzalez-Lopez L, Padilla-Ortega A, Arias-García FI, Sánchez-Zuno GA, Nava-Valdivia CA, Ponce-Guarneros JM, García-Galindo JJ, Perez-Guerrero EE.
    Molecules; 2022 Oct 10; 27(19):. PubMed ID: 36235275
    [Abstract] [Full Text] [Related]

  • 8. Macrophage migration inhibitory factor counter-regulates dexamethasone-induced annexin 1 expression and influences the release of eicosanoids in murine macrophages.
    Sun Y, Wang Y, Li JH, Zhu SH, Tang HT, Xia ZF.
    Immunology; 2013 Oct 10; 140(2):250-8. PubMed ID: 23777345
    [Abstract] [Full Text] [Related]

  • 9. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
    Chuang CC, Chuang YC, Chang WT, Chen CC, Hor LI, Huang AM, Choi PC, Wang CY, Tseng PC, Lin CF.
    BMC Immunol; 2010 Oct 12; 11():50. PubMed ID: 20939898
    [Abstract] [Full Text] [Related]

  • 10. Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.
    Cao WG, Morin M, Sengers V, Metz C, Roger T, Maheux R, Akoum A.
    Hum Reprod; 2006 Feb 12; 21(2):421-8. PubMed ID: 16210389
    [Abstract] [Full Text] [Related]

  • 11. Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
    Sarkar S, Siddiqui AA, Mazumder S, De R, Saha SJ, Banerjee C, Iqbal MS, Adhikari S, Alam A, Roy S, Bandyopadhyay U.
    J Agric Food Chem; 2015 May 27; 63(20):4988-98. PubMed ID: 25929447
    [Abstract] [Full Text] [Related]

  • 12. Polymorphism and expression of macrophage migration inhibitory factor does not contribute to glucocorticoid resistance in idiopathic thrombocytopenic purpura.
    Lao W, Xiang Y, Fang M, Yang X.
    Pharmazie; 2013 Oct 27; 68(10):846-9. PubMed ID: 24273891
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
    Burgos P, Metz C, Bull P, Pincheira R, Massardo L, Errázuriz C, Bono MR, Jacobelli S, González A.
    J Rheumatol; 2000 Jan 27; 27(1):116-27. PubMed ID: 10648027
    [Abstract] [Full Text] [Related]

  • 14. NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells.
    Cho ML, Moon YM, Heo YJ, Woo YJ, Ju JH, Park KS, Kim SI, Park SH, Kim HY, Min JK.
    Immunol Lett; 2009 Mar 24; 123(1):21-30. PubMed ID: 19428548
    [Abstract] [Full Text] [Related]

  • 15. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR, Kim KW, Jung HG, Yoon KS, Oh HJ, Cho ML, Lee SH.
    Arthritis Res Ther; 2011 Mar 14; 13(2):R43. PubMed ID: 21401926
    [Abstract] [Full Text] [Related]

  • 16. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U, García-Iglesias T, Bucala R, Estrada-García I, González-López L, Cerpa-Cruz S, Parra-Rojas I, Gámez-Nava JI, Pérez-Guerrero EE, Muñoz-Valle JF.
    Cell Immunol; 2018 Feb 14; 324():42-49. PubMed ID: 29397904
    [Abstract] [Full Text] [Related]

  • 17. Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.
    Ma L, Xue HB, Guan XH, Shu CM, Zhang YJ, Zhang JH, An RZ.
    Braz J Med Biol Res; 2013 May 14; 46(5):460-4. PubMed ID: 23797494
    [Abstract] [Full Text] [Related]

  • 18. Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.
    Zhang J, Tabush N, Wei C, Luo L.
    Immunobiology; 2023 Mar 14; 228(2):152322. PubMed ID: 36621308
    [Abstract] [Full Text] [Related]

  • 19. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus.
    Li X, Zhang FS, Zhang JH, Wang JY.
    J Rheumatol; 2010 Feb 14; 37(2):316-21. PubMed ID: 20032106
    [Abstract] [Full Text] [Related]

  • 20. MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
    Tu Y, Guo R, Li J, Wang S, Leng L, Deng J, Bucala R, Lu L.
    Front Immunol; 2019 Feb 14; 10():2229. PubMed ID: 31608058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.